| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5913465 | Blood Cells, Molecules, and Diseases | 2014 | 7 Pages |
Abstract
In conclusion, long-term iron chelation therapy with Deferiprone was associated with efficacy and safety similar to that of Deferoxamine. Therefore, in patients with Sickle-Cell-Disease, Deferiprone may represent an effective long-term treatment option.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Giusi Calvaruso, Angela Vitrano, Rosario Di Maggio, Samir Ballas, Martin H. Steinberg, Paolo Rigano, Massimiliano Sacco, Paul Telfer, Disma Renda, Rita Barone, Aurelio Maggio,